Literature DB >> 33094001

Comparison of Imaging Findings between Human Papillomavirus-positive and -Negative Squamous Cell Carcinomas of the Maxillary Sinus.

Masaya Kawaguchi1, Hiroki Kato1, Hiroyuki Tomita2, Akira Hara2, Natsuko Suzui3, Tatsuhiko Miyazaki3, Masayuki Matsuo1.   

Abstract

OBJECTIVES: This study aimed to assess the efficacy of imaging findings when differentiating between human papillomavirus (HPV)-positive and -negative squamous cell carcinomas (SCCs) of the maxillary sinus.
MATERIAL AND METHODS: This study included 37 patients with histopathologically and immunohistochemically confirmed SCCs of the maxillary sinus (three HPV positive and 34 HPV negative). Apparent diffusion coefficients (ADCs), MR signal intensities, CT findings, and maximum standardized uptake (SUVmax) were correlated with the two pathologies.
RESULTS: The minimum ADC (ADCmin) was significantly lower in HPV-positive SCCs than in HPV-negative SCCs (0.50 ± 0.02 vs. 0.70 ± 0.13 × 10-3 mm2/s, P < 0.01). The mean ADC (ADCmean) was not significantly different between HPV-positive SCCs and HPV-negative SCCs (0.84 ± 0.07 vs. 0.97 ± 0.18 ×10-3 mm2/s, P = 0.18). The areas under the receiver operating characteristic curves for ADCmin and ADCmean were 0.986 (P < 0.01) and 0.754 (P < 0.05), respectively. The sensitivity and specificity, with a threshold of ADCmin (0.516 × 10-3 mm2/s) for a diagnosis of HPV-positive SCCs, were 100% and 96%, respectively. However, no significant differences were observed in MR signal intensities, CT findings, and SUVmax between HPV-positive and HPV-negative SCCs.
CONCLUSION: ADCmin is a useful parameter for the differentiation of HPV-positive and HPV-negative SCCs of the maxillary sinus.
© 2020 Published by Scientific Scholar on behalf of Journal of Clinical Imaging Science.

Entities:  

Keywords:  Diffusion-weighted imaging; Human papillomavirus; Magnetic resonance imaging; Maxillary sinus; Squamous cell carcinoma

Year:  2020        PMID: 33094001      PMCID: PMC7568092          DOI: 10.25259/JCIS_116_2020

Source DB:  PubMed          Journal:  J Clin Imaging Sci        ISSN: 2156-5597


  20 in total

1.  Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Authors:  C S Schouten; P de Graaf; E Bloemena; B I Witte; B J M Braakhuis; R H Brakenhoff; C R Leemans; J A Castelijns; R de Bree
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

Review 2.  p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia.

Authors:  Alexandra N Kalof; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2006-07       Impact factor: 3.875

3.  Apparent diffusion coefficients are closely related with high-risk human papilloma virus infection in cervical squamous cell carcinoma patients.

Authors:  Guoxing Zhou; Xiao Chen; Ru Shen; Jun Xu; Yibin Wang; Hong Yu
Journal:  Acta Radiol       Date:  2019-02-05       Impact factor: 1.990

4.  Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas.

Authors:  Juliette P Driessen; Alexander J M van Bemmel; Pauline M W van Kempen; Luuk M Janssen; Chris H J Terhaard; Frank A Pameijer; Stefan M Willems; Inge Stegeman; Wilko Grolman; Marielle E P Philippens
Journal:  Head Neck       Date:  2015-07-14       Impact factor: 3.147

5.  Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.

Authors:  T de Perrot; V Lenoir; M Domingo Ayllón; N Dulguerov; M Pusztaszeri; M Becker
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

6.  Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.

Authors:  Aatur D Singhi; William H Westra
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

7.  Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?

Authors:  Ayse Tuba Karagulle Kendi; Kelly Magliocca; Amanda Corey; Dana C Nickleach; James Galt; Kristin Higgins; Jonathan J Beitler; Mark W El-Deiry; J Trad Wadsworth; Patricia A Hudgins; Nabil F Saba; David M Schuster
Journal:  Clin Nucl Med       Date:  2015-03       Impact factor: 7.794

8.  Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies.

Authors:  Ajaykumar C Morani; Avraham Eisbruch; Thomas E Carey; Samantha J Hauff; Heather M Walline; Suresh K Mukherji
Journal:  J Comput Assist Tomogr       Date:  2013 May-Jun       Impact factor: 1.826

9.  Differentiation of extranodal non-Hodgkins lymphoma from squamous cell carcinoma of the maxillary sinus: a multimodality imaging approach.

Authors:  Hiroki Kato; Masayuki Kanematsu; Haruo Watanabe; Shimpei Kawaguchi; Keisuke Mizuta; Mitsuhiro Aoki
Journal:  Springerplus       Date:  2015-05-15

10.  Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.

Authors:  Jessica Clark; Caroline C Jeffery; Han Zhang; Tim Cooper; Daniel A O'Connell; Jeffrey Harris; Hadi Seikaly; Vincent L Biron
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-09-15
View more
  2 in total

Review 1.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

2.  Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI.

Authors:  Pasqualina D'Urso; Alessia Farneti; Laura Marucci; Simona Marzi; Francesca Piludu; Antonello Vidiri; Giuseppe Sanguineti
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.